Nearly 200 Groups Urge Clinical Trial Bill to Exempt Up to $2,000 in Patient Support
Updated
Updated · CNN · Aug 22
Nearly 200 Groups Urge Clinical Trial Bill to Exempt Up to $2,000 in Patient Support
2 articles · Updated · CNN · Aug 22
Summary
Nearly 200 patient advocacy and public health groups pressed the Senate in July to pass the Clinical Trial Modernization Act, aiming to remove financial barriers that keep willing patients out of studies.
The bill would let sponsors cover copays, deductibles, travel and childcare, and would exclude up to $2,000 in trial support from federal taxes so participants do not jeopardize Medicaid or other income-based benefits.
The push comes despite strong interest: 71% of surveyed adults with chronic conditions said they would likely join a trial, yet two-thirds said their provider had never discussed one and only 9% of adults reported ever being invited.
Recruitment remains a major bottleneck, with up to 86% of trials missing enrollment targets; geography, strict eligibility rules and out-of-pocket costs still limit access, especially outside large academic centers.
HHS added momentum in June by seeking input on easing federal rules that deter sponsors from reimbursing travel and lodging, part of a broader effort to streamline U.S. clinical research.
If 71% of patients want to join clinical trials, what hidden systemic flaw is keeping 91% from ever being invited?
Could paying patients to participate in medical research solve trial delays, or will it create a dangerous new ethical loophole?
As decentralized trials move research into living rooms, will state regulations block vulnerable patients from accessing experimental treatments at home?